vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -12.9%, a 15.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -0.4%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-680.1M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 22.1%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
IRTC vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $340.0M |
| Net Profit | $5.6M | $-13.9M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | -17.2% |
| Net Margin | 2.7% | -12.9% |
| Revenue YoY | 27.1% | -0.4% |
| Net Profit YoY | 518.5% | -131.0% |
| EPS (diluted) | $0.18 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $340.0M | ||
| Q3 25 | $192.9M | $337.7M | ||
| Q2 25 | $186.7M | $319.2M | ||
| Q1 25 | $158.7M | $237.4M | ||
| Q4 24 | $164.3M | $341.5M | ||
| Q3 24 | $147.5M | $292.3M | ||
| Q2 24 | $148.0M | $270.7M | ||
| Q1 24 | $131.9M | $228.1M |
| Q4 25 | $5.6M | $-13.9M | ||
| Q3 25 | $-5.2M | $33.5M | ||
| Q2 25 | $-14.2M | $34.0M | ||
| Q1 25 | $-30.7M | $2.8M | ||
| Q4 24 | $-1.3M | $44.8M | ||
| Q3 24 | $-46.2M | $28.8M | ||
| Q2 24 | $-20.1M | $22.7M | ||
| Q1 24 | $-45.7M | $11.9M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | -17.2% | ||
| Q3 25 | -4.4% | 13.6% | ||
| Q2 25 | -10.0% | 14.5% | ||
| Q1 25 | -20.5% | 2.2% | ||
| Q4 24 | -2.5% | 15.3% | ||
| Q3 24 | -34.1% | 12.8% | ||
| Q2 24 | -15.5% | 10.4% | ||
| Q1 24 | -28.9% | 6.0% |
| Q4 25 | 2.7% | -12.9% | ||
| Q3 25 | -2.7% | 9.9% | ||
| Q2 25 | -7.6% | 10.6% | ||
| Q1 25 | -19.3% | 1.2% | ||
| Q4 24 | -0.8% | 13.1% | ||
| Q3 24 | -31.3% | 9.9% | ||
| Q2 24 | -13.6% | 8.4% | ||
| Q1 24 | -34.6% | 5.2% |
| Q4 25 | $0.18 | $-0.41 | ||
| Q3 25 | $-0.16 | $0.98 | ||
| Q2 25 | $-0.44 | $0.99 | ||
| Q1 25 | $-0.97 | $0.08 | ||
| Q4 24 | $-0.03 | $1.32 | ||
| Q3 24 | $-1.48 | $0.85 | ||
| Q2 24 | $-0.65 | $0.67 | ||
| Q1 24 | $-1.47 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $299.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $1.7B |
| Total Assets | $1.0B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $299.3M | ||
| Q3 25 | $565.2M | $274.8M | ||
| Q2 25 | $545.5M | $233.7M | ||
| Q1 25 | $520.6M | $181.0M | ||
| Q4 24 | $535.6M | $279.3M | ||
| Q3 24 | $522.0M | $179.8M | ||
| Q2 24 | $561.5M | $208.1M | ||
| Q1 24 | $569.1M | $216.5M |
| Q4 25 | $152.7M | $1.7B | ||
| Q3 25 | $121.9M | $1.8B | ||
| Q2 25 | $103.7M | $1.8B | ||
| Q1 25 | $86.7M | $1.7B | ||
| Q4 24 | $90.9M | $1.7B | ||
| Q3 24 | $71.8M | $1.7B | ||
| Q2 24 | $99.2M | $1.7B | ||
| Q1 24 | $90.3M | $1.7B |
| Q4 25 | $1.0B | $5.1B | ||
| Q3 25 | $995.2M | $5.8B | ||
| Q2 25 | $964.0M | $4.7B | ||
| Q1 25 | $926.1M | $4.5B | ||
| Q4 24 | $931.4M | $4.4B | ||
| Q3 24 | $909.7M | $4.6B | ||
| Q2 24 | $919.2M | $4.2B | ||
| Q1 24 | $909.8M | $3.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $-664.3M |
| Free Cash FlowOCF − Capex | $14.5M | $-680.1M |
| FCF MarginFCF / Revenue | 6.9% | -200.0% |
| Capex IntensityCapex / Revenue | 5.6% | 4.6% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $-664.3M | ||
| Q3 25 | $34.9M | $-948.1M | ||
| Q2 25 | $27.7M | $-238.5M | ||
| Q1 25 | $-7.9M | $-281.1M | ||
| Q4 24 | $19.2M | $129.4M | ||
| Q3 24 | $24.3M | $-202.0M | ||
| Q2 24 | $11.8M | $-237.8M | ||
| Q1 24 | $-52.0M | $38.4M |
| Q4 25 | $14.5M | $-680.1M | ||
| Q3 25 | $20.1M | $-950.4M | ||
| Q2 25 | $17.3M | $-241.0M | ||
| Q1 25 | $-17.3M | $-284.7M | ||
| Q4 24 | $12.4M | $116.4M | ||
| Q3 24 | $15.5M | $-204.0M | ||
| Q2 24 | $3.4M | $-241.7M | ||
| Q1 24 | $-61.8M | $35.2M |
| Q4 25 | 6.9% | -200.0% | ||
| Q3 25 | 10.4% | -281.5% | ||
| Q2 25 | 9.3% | -75.5% | ||
| Q1 25 | -10.9% | -120.0% | ||
| Q4 24 | 7.5% | 34.1% | ||
| Q3 24 | 10.5% | -69.8% | ||
| Q2 24 | 2.3% | -89.3% | ||
| Q1 24 | -46.8% | 15.4% |
| Q4 25 | 5.6% | 4.6% | ||
| Q3 25 | 7.7% | 0.7% | ||
| Q2 25 | 5.6% | 0.8% | ||
| Q1 25 | 5.9% | 1.5% | ||
| Q4 24 | 4.2% | 3.8% | ||
| Q3 24 | 6.0% | 0.7% | ||
| Q2 24 | 5.7% | 1.4% | ||
| Q1 24 | 7.4% | 1.4% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | -28.34× | ||
| Q2 25 | — | -7.02× | ||
| Q1 25 | — | -102.07× | ||
| Q4 24 | — | 2.89× | ||
| Q3 24 | — | -7.01× | ||
| Q2 24 | — | -10.49× | ||
| Q1 24 | — | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
WD
Segment breakdown not available.
